These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7725492)

  • 1. Incidence of noncutaneous malignancies in kidney transplant recipients: a 20-year follow-up.
    Mouquet C; Benalia H; Ourahma S; Barrou B; Bitker MO; Luciani J; Chatelain C; Viars P
    Transplant Proc; 1995 Apr; 27(2):1764. PubMed ID: 7725492
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
    Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
    Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and type of malignancies occurring after renal transplantation in conventionally and cyclosporine-treated recipients: analysis of a 20-year period in 1600 patients.
    Hiesse C; Kriaa F; Rieu P; Larue JR; Benoit G; Bellamy J; Blanchet P; Charpentier B
    Transplant Proc; 1995 Feb; 27(1):972-4. PubMed ID: 7879250
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and impact of acute rejection episodes on short- and long-term graft survival in recipients of simultaneous pancreas-kidney transplantation.
    Cantarovich D; Giral M; Josien R; Karam G; Hourmant M; Dantal J; Blancho G; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):1319. PubMed ID: 7878897
    [No Abstract]   [Full Text] [Related]  

  • 8. De novo cancer in transplant recipients.
    Kim MS; Kim SI; Kim YS; Oh CK; Park K
    Transplant Proc; 1996 Jun; 28(3):1651-2. PubMed ID: 8658822
    [No Abstract]   [Full Text] [Related]  

  • 9. Is the incidence of kidney rejection episodes higher in combined kidney/pancreas than in single kidney transplant patients?
    Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP
    Transplant Proc; 1994 Apr; 26(2):535. PubMed ID: 8171541
    [No Abstract]   [Full Text] [Related]  

  • 10. Kaposi's sarcoma in renal transplant recipients: a report on 26 cases from a single institution.
    Qunibi WY; Barri Y; Alfurayh O; Almeshari K; Khan B; Taher S; Sheth K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1402-5. PubMed ID: 8442155
    [No Abstract]   [Full Text] [Related]  

  • 11. [Incidence of tumors in renal transplant patients. Is there a changing tumor pattern in these patients?].
    Hermida Gutiérrez JF; Moreno Sierra J; Blázquez Izquierdo J; Gómez Vegas A; Silmi Moyano A; Prats Sánchez D; Fernández Pérez C; Resel Estévez L
    Arch Esp Urol; 1998 Sep; 51(7):683-91. PubMed ID: 9807894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors of acute rejection in sensitized kidney transplant recipients].
    Huang XE; Fan LP; Li LY; Zhao M; Xia SS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1188-91. PubMed ID: 15485797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does suboptimal immunosuppression contribute to chronic rejection?
    Simić S; Djukanović L; Stojković D; Balgojević R; Sinthoić M; Lezaić V; Radivojević D
    Transplant Proc; 1995 Feb; 27(1):909-10. PubMed ID: 7879226
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and prognosis of cancer following heart transplantation using RATG induction therapy.
    El-Hamamsy I; Stevens LM; Carrier M; Pelletier G; White M; Tremblay F; Perrault LP
    Transpl Int; 2005 Nov; 18(11):1280-5. PubMed ID: 16221159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cyclosporine bioavailability and clinical outcome in renal transplant recipients.
    Schroeder TJ; Hariharan S; First MR
    Transplant Proc; 1994 Oct; 26(5):2787-90. PubMed ID: 7940878
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors contributing to acute rejection in renal transplantation: the role of noncompliance.
    Morrissey PE; Reinert S; Yango A; Gautam A; Monaco A; Gohh R
    Transplant Proc; 2005 Jun; 37(5):2044-7. PubMed ID: 15964334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responsiveness and renal transplantation.
    Scornik JC; Cecka JM
    Clin Transpl; 1996; ():373-9. PubMed ID: 9286583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in renal transplantation recipients.
    Lai MK; Huang CC; Chu SH; Jeng LB; Chuang CK; Chen HW; Chen CS
    Transplant Proc; 1994 Aug; 26(4):1979-80. PubMed ID: 8066640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of recipient age on the clinical course of renal transplantation].
    Palomar R; Ruiz JC; Cotorruelo JG; Zubimendi JA; de Francisco AL; Rodrigo E; Sanz S; Arias M
    Nefrologia; 2001; 21(4):386-91. PubMed ID: 11816515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.